Ausra Ramanauskaite

Ausra Ramanauskaite

Auto-generated profile, based on publicly available information

Ausra Ramanauskaite

Department of Oral Surgery, Implantology and Oral Medicine Goethe University Frankfurt am Main Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Periodontology 2000
Verified
Journal Article
Closed access
PDF file
FSFrank Schwarz
Frank Schwarz
SJSøren Jepsen
Søren Jepsen
KOKarina Obreja
Karina Obreja
MGMaria Elisa Galarraga‐Vinueza
Maria Elisa Galarraga‐Vinueza
ARAusra Ramanauskaite
Ausra Ramanauskaite

28 June 2022 in Clinical Oral Implants Research
Verified
Journal Article
Open access
ARAusra Ramanauskaite
Ausra Ramanauskaite
FSFrank Schwarz
Frank Schwarz
RSRobert Sader
Robert Sader
Aim: To evaluate the influence of the width of keratinized tissue (KT) on the prevalence of peri‐implant diseases, and soft‐ and hard‐tissue stability.Materials and methods: Clinical studies reporting on the prevalence of peri‐implant diseases (primary outcome), plaque index (PI), modified plaque index (mPI), bleeding index (mBI), bleeding on probing (BOP), probing pocket depths (PD), mucosal recession (MR), and marginal bone loss (MBL) and/or patient‐reported outcomes (PROMs; secondary outcomes) were searched. The weighted mean differences (WMD) were estimated for the assessed clinical and radiographic parameters by employing a random‐effect model that considered different KT widths (i.e., <2 and ≥2 mm).Results: Twenty‐two articles describing 21 studies (15 cross‐sectional, five longitudinal comparative studies, and one case series with pre–post design) with an overall high to low risk of bias were included. Peri‐implant mucositis and peri‐implantitis affected 20.8% to 42% and at 10.5% to 44% of the implants with reduced or absent KT (i.e., 0 mm were 20.5% to 53% and 5.1% to 8%, respectively. Significant differences between implants with KT < 2 mm and those with KT ≥ 2 mm were revealed for WMD for BOP, mPI, PI, MBL, and MR all favoring implants with KT ≥ 2 mm.Conclusion: Reduced KT width is associated with an increased prevalence of peri‐implantitis, plaque accumulation, soft‐tissue inflammation, mucosal recession, marginal bone loss, and greater patient discomfort.

15 November 2021 in International Journal of Implant Dentistry
Verified
Journal Article
Open access
PDF file
ARAusra Ramanauskaite
Ausra Ramanauskaite
TFTobias Fretwurst
Tobias Fretwurst
FSFrank Schwarz
Frank Schwarz
Purpose: To evaluate the efficacy of alternative or adjunctive measures to conventional non-surgical or surgical treatment of peri-implant mucositis and peri-implantitis.Material and methods: Prospective randomized and nonrandomized controlled studies comparing alternative or adjunctive measures, and reporting on changes in bleeding scores (i.e., bleed0ing index (BI) or bleeding on probing (BOP)), probing depth (PD) values or suppuration (SUPP) were searched.Results: Peri-implant mucositis: adjunctive use of local antiseptics lead to greater PD reduction (weighted mean difference (WMD) = − 0.23 mm;p = 0.03, respectively), whereas changes in BOP were comparable (WMD = − 5.30%;p = 0.29). Non-surgical treatment of peri-implantitis: alternative measures for biofilm removal and systemic antibiotics yielded higher BOP reduction (WMD = − 28.09%;p = 0.01 and WMD = − 17.35%;p = 0.01, respectively). Surgical non-reconstructive peri-implantitis treatment: WMD in PD amounted to − 1.11 mm favoring adjunctive implantoplasty (p = 0.02). Adjunctive reconstructive measures lead to significantly higher radiographic bone defect fill/reduction (WMD = 56.46%;p = 0.01 and WMD = − 1.47 mm;p = 0.01), PD (− 0.51 mm;p = 0.01) and lower soft-tissue recession (WMD = − 0.63 mm;p = 0.01), while changes in BOP were not significant (WMD = − 11.11%;p = 0.11).Conclusions: Alternative and adjunctive measures provided no beneficial effect in resolving peri-implant mucositis, while alternative measures were superior in reducing BOP values following non-surgical treatment of peri-implantitis. Adjunctive reconstructive measures were beneficial regarding radiographic bone-defect fill/reduction, PD reduction and lower soft-tissue recession, although they did not improve the resolution of mucosal inflammation.

12 October 2021 in Clinical Oral Implants Research
Verified
Journal Article
Open access
PDF file
FSFrank Schwarz
Frank Schwarz
GAGil Alcoforado
Gil Alcoforado
AGAdrian Guerrero
Adrian Guerrero
DJDaniel Jönsson
Daniel Jönsson
BKBjörn Klinge
Björn Klinge
LHLisa Heitz‐Mayfield
Lisa Heitz‐Mayfield
Objective: To evaluate the influence of implant and prosthetic components on peri‐implant tissue health. A further aim was to evaluate peri‐implant soft‐tissue changes following surgical peri‐implantitis treatment.Materials and methods: Group discussions based on two systematic reviews (SR) and one critical review (CR) addressed (i) the influence of implant material and surface characteristics on the incidence and progression of peri‐implantitis, (ii) implant and restorative design elements and the associated risk for peri‐implant diseases, and (iii) peri‐implant soft‐tissue level changes and patient‐reported outcomes following peri‐implantitis treatment. Consensus statements, clinical recommendations, and implications for future research were discussed within the group and approved during plenary sessions.Results: Data from preclinical in vivo studies demonstrated significantly greater radiographic bone loss and increased area of inflammatory infiltrate at modified compared to non‐modified surface implants. Limited clinical data did not show differences between modified and non‐modified implant surfaces in incidence or progression of peri‐implantitis (SR). There is some evidence that restricted accessibility for oral hygiene and an emergence angle of >30 combined with a convex emergence profile of the abutment/prosthesis are associated with an increased risk for peri‐implantitis (CR). Reconstructive therapy for peri‐implantitis resulted in significantly less soft‐tissue recession, when compared with access flap. Implantoplasty or the adjunctive use of a barrier membrane had no influence on the extent of peri‐implant mucosal recession following peri‐implantitis treatment (SR).Conclusions: Prosthesis overcontouring and impaired access to oral hygiene procedures increases risk for peri‐implantitis. When indicated, reconstructive peri‐implantitis treatment may facilitate the maintenance of post‐operative peri‐implant soft‐tissue levels.

1 February 2022 in Periodontology 2000
Verified
Journal Article
Closed access
PDF file
ARAusra Ramanauskaite
Ausra Ramanauskaite
RSRobert Sader
Robert Sader

16 April 2018 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
ARAusra Ramanauskaite
Ausra Ramanauskaite
Kathrin BeckerKathrin Becker
Kathrin Becker
FSFrank Schwarz
Frank Schwarz